1-232403478-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020808.5(SIPA1L2):c.4910G>A(p.Gly1637Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,613,940 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020808.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIPA1L2 | NM_020808.5 | c.4910G>A | p.Gly1637Asp | missense_variant | 21/23 | ENST00000674635.1 | NP_065859.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIPA1L2 | ENST00000674635.1 | c.4910G>A | p.Gly1637Asp | missense_variant | 21/23 | NM_020808.5 | ENSP00000502693.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000522 AC: 13AN: 249152Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135162
GnomAD4 exome AF: 0.000113 AC: 165AN: 1461698Hom.: 1 Cov.: 31 AF XY: 0.0000880 AC XY: 64AN XY: 727154
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74436
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2023 | The c.4910G>A (p.G1637D) alteration is located in exon 19 (coding exon 19) of the SIPA1L2 gene. This alteration results from a G to A substitution at nucleotide position 4910, causing the glycine (G) at amino acid position 1637 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at